Correlation Between C-Bond Systems and BioNexus Gene
Can any of the company-specific risk be diversified away by investing in both C-Bond Systems and BioNexus Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C-Bond Systems and BioNexus Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C Bond Systems and BioNexus Gene Lab, you can compare the effects of market volatilities on C-Bond Systems and BioNexus Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C-Bond Systems with a short position of BioNexus Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of C-Bond Systems and BioNexus Gene.
Diversification Opportunities for C-Bond Systems and BioNexus Gene
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between C-Bond and BioNexus is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding C Bond Systems and BioNexus Gene Lab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNexus Gene Lab and C-Bond Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C Bond Systems are associated (or correlated) with BioNexus Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNexus Gene Lab has no effect on the direction of C-Bond Systems i.e., C-Bond Systems and BioNexus Gene go up and down completely randomly.
Pair Corralation between C-Bond Systems and BioNexus Gene
Given the investment horizon of 90 days C Bond Systems is expected to under-perform the BioNexus Gene. But the pink sheet apears to be less risky and, when comparing its historical volatility, C Bond Systems is 2.14 times less risky than BioNexus Gene. The pink sheet trades about -0.03 of its potential returns per unit of risk. The BioNexus Gene Lab is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 79.00 in BioNexus Gene Lab on September 2, 2024 and sell it today you would lose (56.00) from holding BioNexus Gene Lab or give up 70.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
C Bond Systems vs. BioNexus Gene Lab
Performance |
| Timeline |
| C Bond Systems |
| BioNexus Gene Lab |
C-Bond Systems and BioNexus Gene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C-Bond Systems and BioNexus Gene
The main advantage of trading using opposite C-Bond Systems and BioNexus Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C-Bond Systems position performs unexpectedly, BioNexus Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNexus Gene will offset losses from the drop in BioNexus Gene's long position.| C-Bond Systems vs. Sherwin Williams Co | C-Bond Systems vs. Air Liquide SA | C-Bond Systems vs. Air Products and | C-Bond Systems vs. Ecolab Inc |
| BioNexus Gene vs. Linde plc Ordinary | BioNexus Gene vs. Air Products and | BioNexus Gene vs. Aquagold International | BioNexus Gene vs. Thrivent High Yield |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |